Public-domain · open source
OpenJurist
← 118 F.3d 955 - Softel, Inc. v. Dragon Medical & Scientific Communications, Inc.

Softel, Inc. v. Dragon Medical & Scientific Communications, Inc.’s Empirical Analysis

118 F.3d 955 · 1997

Citation profile

159
cited by 159 later decisions
1
states following
May 2024
most recently cited

18 federal appellate · 7 district · 1 state decisions

How this case has been cited

Cited by 159 later decisions — most recently May 2024 · most notably Reilly v. NatWest Markets Group Inc. (1999), Montgomery v. Noga (1999)

18 federal appellate · 7 district · 1 state decisions

7201997200020102020decided

Later decisions citing this case, by decade. The current decade is in progress, and our corpus holds fewer opinions from the most recent years, so the latest bars are undercounted — not a real decline.

Relationships

Relies on Klaxon Co. v. Stentor Electric Manufacturing Co. · Feist Publications, Inc. v. Rural Telephone Service Co. · Sony Corporation of America v. Universal City Studios Inc · Intercontinental Planning, Ltd. v. Daystrom Inc. · Computer Associates International, Inc. v. Altai, Inc.

Most-quoted passages

The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 159 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.

  1. “(1) the party's explanation for the failure to comply ..., (2) the importance of the testimony of the precluded witness, (3) the prejudice suffered by the opposing party ...; and (4) the possibility of a continuance.”
    7 later decisions quote this exact passage · from the majority
  2. “(1) that the [product] at issue originated with the plaintiff; (2) that [the] origin of the [product] was falsely designated by the defendant; (3) that the false designation of origin was likely to cause consumer confusion; and (4) that the plaintiff was harmed by the defendant's false designation of origin.”
    3 later decisions quote this exact passage · from the majority
  3. “[A] trade secret is 'any formula, pattern, device or compilation of information which is used in one's business, and which gives [the owner] an opportunity to obtain an advantage over competitors who do not know or use it.'”
    3 later decisions quote this exact passage · from the majority

How this case has been treated — in progress

Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.